Deep Blue has played Huawei's trump card.

I don't want to be low-key anymore.

wallstreetcnJul 25 22:17 ET

Interest rate cut! China's 1-year and 5-year LPRs were lowered by 10BP on July 1st. How will the market develop in the future?

The one-year LPR for July is 3.35%, and the LPR for more than five years is 3.85%, both down by 10 basis points from the previous value.

wallstreetcnJul 21 22:42 ET

Sodium-electric and semi-solid, half flame and half seawater | Jianzhi Research

Thanks to the new energy autos achieving a record high in delivery, the production, sales and installation volume of power batteries also hit a new high in June this year in all dimensions.

wallstreetcnJul 11 06:18 ET

In 2019, the head brokerage's secretary was appointed as the "older insurance agent".

China Securities Co., Ltd., a leading brokerage firm, recently announced an important personnel change. The company's board of directors has approved the appointment of Liu Naisheng as the company's board secretary, and Wang Guangxue will no longer hold this position. Liu Naisheng is a veteran investment banker and the first generation of securities salespeople in China. He has led successful underwriting projects for numerous companies and is best known for overseeing the IPO projects for Contemporary Amperex Technology and the representative Beijing-Shanghai High Speed Railway. As a seasoned securities industry veteran, Liu Naisheng's appointment as board secretary after seven years of serving as a senior executive (executive committee member) at China Securities Co., Ltd. is certainly worth following in terms of his future contributions. According to publicly available information about skilled post-70s workers, Liu Naisheng belongs to the post-70s generation of securities professionals.

wallstreetcnJul 10 10:21 ET

"Ningwang" targets the new trillion-dollar track.

Looking for growth opportunities.

wallstreetcnJul 5 11:03 ET

A-share market review: Shenzhen Component Index and Chinext Price Index turned red, with a transaction amount continuing to be below 600 billion yuan and pharmaceutical stocks rebounding significantly.

Today, the major A-share indexes opened low and rebounded, with all three indexes hitting new lows since February at one point. In the afternoon, they bottomed out and rebounded, with the Shenzhen Component Index and the Chinext Price Index both turning positive. The Shanghai Composite Index fell by 0.26% to 2949 points, the Shenzhen Component Index rose by 0.25%, and the Chinext Price Index rose by 0.51%. More than 3900 stocks rose, with a total turnover of 574.9 billion yuan for the day, which was lower than 600 billion yuan for the third consecutive day. On the market, the pharmaceutical sector rose across the board, with CRO, innovative drugs, and weight loss drugs leading the way, with Tigermed up nearly 8% and Luoxin Pharmaceuticals Group Stock up by the limit; the precious metals sector rose, with Zhongjin Gold Corp.,Ltd up nearly 9%; the medical equipment sector rose, with Changjiang Pharmaceutical Group up 20CM.

Gelonghui FinanceJul 5 03:12 ET